ARCHIVES

Phase II Study: Proton Therapy Can Have Similar Success Rate, Smaller Level of Risk in Treatment of Hodgkin Lymphoma

This article is from The Cancer Letter archive.

Vol. 37 No. 7 | July 25, 2014

Download PDF Visit The Full Archive

Related Articles

In Congress: $135 Million Expected For DOD Breast Cancer Research Program

July 24, 1998

Zometa Prevents Bone Loss In Premenopausal Women

August 29, 2008

Rauscher Summarizes Criticism of Cooperative Groups; Changes To Await May 22024 Conference

May 9, 1975

FDA Declares Taxol Orphan Drug For KS; Can IVAX Break Bristol’s Exclusivity?

August 15, 1997

Six Institutions Get Awards For LAK-IL-2 Trials

February 7, 1986

Compliance Grants Awarded, Contract Pending On Differences In Black/White Survival

November 19, 1982